Dr. Christopher Haggarty-Weir
I am currently based at the Roslin Institute as the Industrial Vaccinology Liaison Officer under the IVVN, where my role is to focus on the industry side of veterinary vaccine development.
I completed my biomedical science undergraduate at USC where I interned in forensic pathology and carried out research in immunology, medical microbiology and cardiovascular pharmacology. Following this I completed my Masters of Molecular Biology in the lab of Prof. Glenn King at the Institute for Molecular Bioscience (University of Queensland), where I worked on anti-malarial peptide development and fungal parasite bioinformatics. I then carried out a Universitas 21 joint Ph.D between the University of Melbourne (Walter and Eliza Hall Institute, Division of Infection and Immunity) and the University of Edinburgh (School of Chemistry) in molecular parasitology and biophysical chemistry. My research focused on malaria vaccine development under Prof. Alan Cowman, and I also completed summer school at MIT's Sloan School of Management focused on entrepreneurship. During my time in Edinburgh, I worked part-time at Edinburgh Innovations to help commercialize the Uni's biotech and medical research, and consulted for Seven Hills Venture Partners as a venture capital analyst. Currently, I am completing my MBA in Finance and Management at the University of the People in conjunction with Yale and Oxford Uni's, and was recently elected a Member of the Royal Society of Biology and the Royal Society of Chemistry.
My interests include writing for MostlyScience.com, carrying out investment analysis on biotech/pharma/healthcare companies, philosophy, music and analyses of bad movies.